Clinical investigation of medicinal products used in the treatment of osteoarthritis - Scientific guideline

HumanScientific guidelines

Bulgarian is available via eTranslation, the European Commission's machine translation service.

Translate to Bulgarian | Important information about machine translation

This document provides guidance on the clinical evaluation of medicinal products in the treatment of osteoarthritis.

Keywords: Osteoarthritis, symptom modifying drugs, structure modifying drugs, non-steroidal anti-inflammatory drugs (NSAIDs), clinical development

Current effective version

Guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis

Adopted Reference Number: CPMP/EWP/784/97 Rev. 1 Legal effective date:

English (EN) (87.62 KB - PDF)

Публикувано за първи път: Последна актуализация:
Виж

Document history

Guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis

Adopted Reference Number: CPMP/EWP/784/97 Rev. 1 Legal effective date:

English (EN) (87.62 KB - PDF)

Публикувано за първи път: Последна актуализация:
Виж

Overview of comments received on draft guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis

Adopted Reference Number: EMA/818496/2009

English (EN) (223.85 KB - PDF)

Публикувано за първи път: Последна актуализация:
Виж

Draft guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis

Draft: consultation closed Reference Number: CPMP/EWP/784/97 Rev. 1

English (EN) (94.59 KB - PDF)

Публикувано за първи път: Последна актуализация:
Виж

Concept paper on the need for revision of points to consider on clinical investigation of medicinal products for the treatment of osteoarthritis (CPMP/EWP/784/97)

Reference Number: EMEA/CHMP/EWP/141412/2008

English (EN) (44.53 KB - PDF)

Публикувано за първи път: Последна актуализация:
Виж

Share this page